Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medipal Holdings's share price for the quarter that ended in Mar. 2026 was $17.675. Medipal Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 205 Mil. Therefore, Medipal Holdings's market cap for the quarter that ended in Mar. 2026 was $3,618 Mil.
Medipal Holdings's quarterly market cap
declined
from Sep. 2025 ($3,766 Mil) to Dec. 2025 ($3,664 Mil) and
declined
from Dec. 2025 ($3,664 Mil) to Mar. 2026 ($3,618 Mil).
Medipal Holdings's annual market cap
increased
from Mar. 2024 ($3,245 Mil) to Mar. 2025 ($3,358 Mil) and
increased
from Mar. 2025 ($3,358 Mil) to Mar. 2026 ($3,618 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medipal Holdings's Enterprise Value for Today is $2,420 Mil.
Medipal Holdings (OTCPK:MAHLY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medipal Holdings Market Cap Related Terms
Medipal Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medipal Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medipal Holdings's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Market Cap of $3,333 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medipal Holdings and its competitors. According to the industry distribution chart, Medipal Holdings ranks #11 out of 120 companies in the Medical Distribution industry, placing it in the top 9.2%.
Is Medipal Holdings' Market Cap too high?
Medipal Holdings' current Market Cap is $3,333 Mil. The Medical Distribution industry median Market Cap is 144.63. Medipal Holdings' value of $3,333 Mil is 2204.5% above this industry median. Based on the distribution chart, Medipal Holdings ranks #11 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #11 out of 120 companies for Market Cap. This places Medipal Holdings in the top 9% of its industry — outperforming the majority of peers. The industry median Market Cap is 144.63. Medipal Holdings' value of $3,333 Mil is 2204.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 144.63, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Market Cap of $3,333 Mil is 2204.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Market Cap is 144.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Market Cap is $3,333 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.44, compared to a current price of $16.28 — trading 1% below its estimated fair value. The current Market Cap is $3,333 Mil and 2204.5% above the Medical Distribution industry median of 144.63. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Market Cap is $3,333 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $16.28 is trading 1% below its estimated GF Value™ of $16.44.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Market Cap: $3,333 Mil
GF Value™: $16.44 vs. price of $16.28 (1% below fair value)
Industry Position: 2204.5% above the Medical Distribution median (#11 of 120)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
